TOIIW (STOCKS)
The Oncology Institute, Inc. Warrant
$0.044800
+0.002300 (+5.41%)
Prev close: $0.042500
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical Or Nursing Services
- CEO
- Daniel Virnich, MD, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 825
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $545.76M |
| Benefits Costs and Expenses | $589.41M |
| Costs And Expenses | $589.41M |
| Nonoperating Income/Loss | -$10.96M |
| Operating Expenses | $578.45M |
| Selling, General, and Administrative Expenses | $108.41M |
| Depreciation and Amortization | $6.78M |
| Other Operating Expenses | $463.26M |
| Operating Income/Loss | -$32.69M |
| Income/Loss From Continuing Operations After Tax | -$43.51M |
| Income/Loss From Continuing Operations Before Tax | -$43.51M |
| Income Tax Expense/Benefit | -$131.00K |
| Net Income/Loss | -$43.51M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$43.51M |
| Net Income/Loss Available To Common Stockholders, Basic | -$39.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$4.21M |
| Preferred Stock Dividends And Other Adjustments | -$4.21M |
| Basic Earnings Per Share | -$0.35 |
| Diluted Earnings Per Share | -$0.35 |
| Basic Average Shares | 117,092,165 |
| Diluted Average Shares | 117,092,165 |
| Assets | $168.23M |
| Current Assets | $116.86M |
| Inventory | $24.29M |
| Other Current Assets | $92.57M |
| Noncurrent Assets | $51.37M |
| Fixed Assets | $10.70M |
| Intangible Assets | $10.30M |
| Other Non-current Assets | $30.37M |
| Liabilities | $184.52M |
| Current Liabilities | $79.35M |
| Accounts Payable | $47.65M |
| Wages | $5.80M |
| Other Current Liabilities | $25.90M |
| Noncurrent Liabilities | $105.16M |
| Equity | -$16.29M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$16.29M |
| Liabilities And Equity | $168.23M |
| Net Cash Flow From Operating Activities | -$21.81M |
| Net Cash Flow From Operating Activities, Continuing | -$21.81M |
| Net Cash Flow From Investing Activities | -$3.91M |
| Net Cash Flow From Investing Activities, Continuing | -$3.91M |
| Net Cash Flow From Financing Activities | $16.27M |
| Net Cash Flow From Financing Activities, Continuing | $16.27M |
| Net Cash Flow | -$9.46M |
| Net Cash Flow, Continuing | -$9.46M |
| Comprehensive Income/Loss | -$43.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$43.51M |
| Other Comprehensive Income/Loss | $0.00 |